DNAtix

Company Overview

Snapshot

Founded in February 2018 by Ofer Lidsky, Dr. Ichak Adizes, and Dr. Tal Sines, DNAtix operated with 1–10 employees. The company was granted a US Patent for Personal Identity Management Using Blockchain Technology in September 2020.

Business overview

DNAtix developed a smart platform for cyber genetics, providing anonymous and encrypted genetic services. The company's core technology facilitated the analysis, storage, and transfer of digitized DNA sequences through a direct-to-consumer platform. It also offered an open-source technology for developers, researchers, and institutions to build upon. DNAtix operated in the Cyber Security and Digital Health and Medical Technologies sectors, serving markets related to genetic testing, biotechnology, and blockchain-based data management for both B2C and B2B clients.

Strategic signal

In September 2020, DNAtix was granted a US Patent for Personal Identity Management Using Blockchain Technology. This patent signals the company's commitment to intellectual property in the intersection of genetics and secure digital identity, potentially validating its innovative approach to safeguarding sensitive genetic data.

Company Intelligence Q&A

What is DNAtix's primary focus?

DNAtix focuses on developing a smart platform for cyber genetics, offering anonymous and encrypted genetic services including the analysis, storage, and transfer of digitized DNA sequences.

When was DNAtix founded?

DNAtix was founded in February 2018.

What significant intellectual property milestone did DNAtix achieve?

In September 2020, DNAtix was granted a US Patent for Personal Identity Management Using Blockchain Technology.

What was a key technological achievement for DNAtix in September 2018?

In September 2018, DNAtix set a new record by compressing DNA sequences to 99% of their original size.

What was a notable partnership for DNAtix in August 2018?

In August 2018, Mapmygenome partnered with DNAtix, a blockchain startup, to advance genetic services.